Ampio Pharmaceuticals, Inc. (AMPE)
OTCMKTS · Delayed Price · Currency is USD
0.0029
0.00 (0.00%)
Jul 31, 2025, 8:00 PM EDT
Ampio Pharmaceuticals Employees
Ampio Pharmaceuticals had 6 employees as of December 31, 2023. The number of employees decreased by 2 or -25.00% compared to the previous year.
Employees
6
Change (1Y)
-2
Growth (1Y)
-25.00%
Revenue / Employee
n/a
Profits / Employee
-$1,438,667
Market Cap
3.29K
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 6 | -2 | -25.00% |
Dec 31, 2022 | 8 | -12 | -60.00% |
Dec 31, 2021 | 20 | 2 | 11.11% |
Dec 31, 2020 | 18 | -5 | -21.74% |
Dec 31, 2019 | 23 | 1 | 4.55% |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Endo, Inc. | 3,116 |
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 68 |
Glass House Brands | 374 |
CytoDyn | 9 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Ampio Pharmaceuticals News
- 1 year ago - Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation - PRNewsWire
- 1 year ago - Ampio Announces Voluntary Delisting and SEC Deregistration - PRNewsWire
- 1 year ago - Ampio Provides Update on Results from Pre-IND Enabling Studies - PRNewsWire
- 1 year ago - Ampio Provides Litigation Update - Reports Settlement in Principle of Certain Pending Legal Actions - PRNewsWire
- 1 year ago - Ampio Pharmaceuticals to Present at the Emerging Growth Conference - PRNewsWire
- 1 year ago - Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201 - PRNewsWire
- 2 years ago - Ampio Pharmaceuticals Announces Reverse Stock Split - PRNewsWire
- 2 years ago - Ampio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common Stock - PRNewsWire